U.S. RESEARCH ROUNDUP-Amkor Technology, Boeing, Nogin

Cerence

28/11/2023 06:48

Nov 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amkor
Technology, Boeing and Nogin on Tuesday. 
    
  HIGHLIGHTS        
                 * Amkor Technology Inc  AMKR.O : Melius Research initiates coverage with buy
 rating 
 
                 * Boeing  BA.N : RBC raises to outperform from sector perform 
 
                 * Lexeo Therapeutics Inc  LXEO.O : RBC initiates coverage with outperform rating
 
                 * Nogin Inc  NOGN.O : Alliance Global Partners cuts to sell from neutral 
 
                 * Welltower Inc  WELL.N : RBC cuts to sector perform from outperform 
 
                
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.         

                 * Academy Sports and Outdoors Inc  ASO.O : JP Morgan cuts target price to $55 from $63 
 
                 * Academy Sports and Outdoors Inc  ASO.O : Stephens cuts target price to $71 from $75 
 
                 * Acelyrin Inc  SLRN.O : Jefferies cuts target price to $12 from $15 
 
                 * Aerovironment Inc  AVAV.O : Baird raises target price to $152 from $128 
 
                 * Affirm Holdings Inc  AFRM.O : Jefferies raises to hold; raises target to $30 from $9.50 
 
                 * Aldeyra Therapeutics Inc  ALDX.O : Jonestrading cuts target price to $7 from $10 
 
                 * Amkor Technology Inc  AMKR.O : Melius Research initiates coverage with buy rating 
 
                 * Amkor Technology Inc  AMKR.O : Melius Research initiates coverage with target price $35 
 
                 * Boeing  BA.N : RBC raises target price to $275 from $200 
 
                 * Boeing  BA.N : RBC raises to outperform from sector perform 
 
                 * Caretrust REIT Inc  CTRE.N : RBC raises target price to $25 from $23 
 
                 * Caseys General Stores Inc  CASY.O : RBC raises target price to $291 from $284 
 
                 * Cerence Inc  CRNC.O : TD Cowen cuts target price to $23 from $35 
 
                 * Cerence Inc  CRNC.O : Wells Fargo cuts target price to $25 from $32 
 
                 * Core & Main Inc  CNM.N : RBC raises target price to $38 from $34 
 
                 * Estée Lauder Companies  EL.N : HSBC initiates coverage with buy rating and PT $180 
 
                 * Evolent Health Inc  EVH.N : RBC cuts target price to $42 from $44 
 
                 * First Northwest Bancorp  FNWB.O : Piper Sandler raises target price to $15 from $13 
 
                 * Lexeo Therapeutics Inc  LXEO.O : RBC initiates coverage with outperform rating
 
                 * Lexeo Therapeutics Inc  LXEO.O : RBC initiates coverage with price target $22 
 
                 * Medical Properties Trust Inc  MPW.N : RBC cuts target price to $8 from $10 
 
                 * Nogin Inc  NOGN.O : Alliance Global Partners cuts to sell from neutral 
 
                 * Redwood Trust Inc  RWT.N : Raymond James cuts target price to $9 from $10 
 
                 * Regeneron Pharmaceuticals Inc  REGN.O : Jefferies raises target price to $937 from $935 
 
                 * Ventas Inc  VTR.N : RBC cuts target price to $52 from $53 
 
                 * Welltower Inc  WELL.N : RBC cuts to sector perform from outperform 
 
                 * Welltower Inc  WELL.N : RBC raises target price to $97 from $92 
 
                 * Zscaler Inc  ZS.O : Evercore ISI raises target price to $215 from $200 
 
                 * Zscaler Inc  ZS.O : Piper Sandler raises target price to $220 from $190 
 
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))